시장보고서
상품코드
1633663

교합 디바이스 시장 규모, 점유율, 성장 분석 : 제품별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)

Occlusion Devices Market Size, Share, Growth Analysis, By Product (Occlusion Removal Devices, Embolization Devices), By Application (Neurology, Cardiology), By End User, By Region - Industry Forecast 2025-2032

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 232 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 교합 디바이스 시장 규모는 2023년에 29억 4,000만 달러에 달하며, 예측 기간(2025-2032년)의 CAGR은 5.1%로, 2024년 30억 9,000만 달러에서 2032년에는 46억 달러로 성장할 전망입니다.

세계 교합 디바이스 시장은 심혈관 질환, 신경혈관 질환, 말초 혈관 질환의 유병률 증가에 힘입어 견고한 성장 궤도에 있습니다. 폐색제거 장비, 색전술 장비, 지지 장비 등의 주요 제품은 효과적인 치료 프로토콜에 필수적인 제품입니다. 고령화와 최소 침습 수술 기술의 발전은 시장 확대를 더욱 촉진하고 있습니다. 또한 혈관내 치료로의 전환과 외래수술센터(ASC)와 같은 외래 환자 선호도가 높아지면서 수요가 증가하고 있습니다. 북미는 심혈관 질환의 높은 유병률과 주요 제조업체의 존재로 인해 시장을 주도하고 있습니다. 반면, 유럽과 아시아태평양은 의료 인프라가 개선되고 환자들의 인식이 높아지면서 큰 성장세를 보이고 있습니다. 이러한 추세는 가까운 미래에도 지속될 것으로 예상됩니다.

목차

서론

  • 조사의 목적
  • 조사 범위
  • 정의

조사 방법

  • 정보 조달
  • 2차 데이터와 1차 데이터 방법
  • 시장 규모 예측
  • 시장의 전제조건과 제한

개요

  • 세계 시장 전망
  • 공급과 수요의 동향 분석
  • 부문별 기회 분석

시장 역학과 전망

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 촉진요인과 기회
    • 억제요인과 과제
  • Porter의 산업 분석

주요 시장 인사이트

  • 주요 성공 요인
  • 경쟁의 정도
  • 주요 투자 기회
  • 시장 에코시스템
  • 시장의 매력 지수(2024년)
  • PESTEL 분석
  • 거시경제 지표
  • 밸류체인 분석
  • 가격 분석
  • 규제 상황
  • 사례 연구
  • 기술의 진보

교합 디바이스 시장 규모 : 제품별과 CAGR(2025-2032년)

  • 시장 개요
  • 폐쇄 제거 기기
    • 풍선 교합 디바이스
    • 스텐트 회수기
    • 코일 리트리버
    • 석션·흡인 디바이스
  • 색전 디바이스
    • 색전코일
    • 액체색전제
    • Tubal Occlusion Devices
  • 서포트 디바이스
    • 마이크로카테터
    • 가이드와이어

교합 디바이스 시장 규모 : 용도별과 CAGR(2025-2032년)

  • 시장 개요
  • 신경학
  • 심장병학
  • 말초혈관 질환
  • 비뇨기과
  • 종양학
  • 부인과

교합 디바이스 시장 규모 : 최종사용자별과 CAGR(2025-2032년)

  • 시장 개요
  • 병원
  • 진단 센터
  • 외과 센터
  • 외래 진료 센터
  • 조사실 및 학술기관

교합 디바이스 시장 규모와 CAGR(2025-2032년)

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 이탈리아
    • 기타 유럽 지역
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카 지역
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 정보

  • 상위 5사의 비교
  • 주요 기업의 시장 포지셔닝(2024년)
  • 주요 시장 기업이 채택한 전략
  • 시장의 최근 동향
  • 기업의 시장 점유율 분석(2024년)
  • 주요 기업의 기업 개요
    • 회사 개요
    • 제품 포트폴리오 분석
    • 부문별 점유율 분석
    • 매출의 전년대비 비교(2022-2024년)

주요 기업 개요

  • Boston Scientific Corporation(United States)
  • Medtronic PLC(Ireland)
  • Terumo Corporation(Japan)
  • Stryker Corporation(United States)
  • Penumbra, Inc.(United States)
  • Abbott Laboratories(United States)
  • Edwards Lifesciences Corporation(United States)
  • Johnson & Johnson(United States)
  • Merit Medical Systems, Inc.(United States)
  • Lepu Medical Technology Co., Ltd.(China)
  • Asahi Intecc Co., Ltd.(Japan)
  • AngioDynamics, Inc.(United States)
  • Cardinal Health, Inc.(United States)
  • Avinger, Inc.(United States)
  • B. Braun Melsungen AG(Germany)
  • C.R. Bard, Inc.(United States)
  • Cook Medical Incorporated(United States)
  • Acrostak International Distribution Sarl(Switzerland)

결론과 권장사항

KSA 25.02.17

Global Occlusion Devices Market size was valued at USD 2.94 billion in 2023 and is poised to grow from USD 3.09 billion in 2024 to USD 4.6 billion by 2032, growing at a CAGR of 5.1% during the forecast period (2025-2032).

The global occlusion devices market is on a robust growth trajectory, driven by the rising incidence of cardiovascular diseases, neurovascular disorders, and peripheral vascular conditions. Key products including occlusion removal devices, embolization devices, and support devices are integral to effective treatment protocols. The aging population and advancements in minimally invasive surgical techniques are further propelling market expansion. Moreover, the shift towards endovascular procedures and an increasing preference for outpatient settings, like ambulatory surgical centers, are boosting demand. North America leads the market, thanks to a high prevalence of cardiovascular issues and the presence of major manufacturers. Meanwhile, Europe and Asia-Pacific are experiencing significant growth due to enhanced healthcare infrastructure and rising patient awareness. This trend is expected to persist in the near future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Occlusion Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Occlusion Devices Market Segmental Analysis

Global Occlusion Devices Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Occlusion Removal Devices, Embolization Devices and Support Devices. Based on Application, the market is segmented into Neurology, Cardiology, Peripheral Vascular Diseases, Urology,oncologyand Gynecology. Based on End User, the market is segmented into Hospitals, Diagnostic Centers,, Surgical Centers, Ambulatory Care Centers and Research Laboratories & Academic Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Occlusion Devices Market

The global occlusion devices market is primarily driven by the rising prevalence of cardiovascular and neurovascular diseases, as well as peripheral vascular conditions. The growing incidence of these health issues necessitates effective therapeutic solutions like occlusion devices to restore blood flow and mitigate complications. This demand is further amplified by an aging population and increasing unhealthy lifestyle choices. Additionally, advancements in minimally invasive techniques have transformed occlusion treatment, offering patients non-surgical options that reduce trauma, expedite recovery, and enhance outcomes. The introduction of innovative devices, including occlusion removal and embolization devices, with improved safety and efficacy, is fostering significant market growth.

Restraints in the Global Occlusion Devices Market

The global occlusion devices market faces several significant restraints, primarily due to rigorous regulatory approval processes designed to ensure patient safety and product effectiveness. Securing necessary approvals, such as those from the FDA or obtaining CE marking, is often a lengthy and expensive endeavor. This regulatory landscape presents considerable hurdles, especially for small and medium-sized enterprises looking to enter or enhance their market footprint. Additionally, the high costs associated with manufacturing occlusion devices-encompassing occlusion removal, embolization, and support devices-are another limiting factor. The substantial expenses tied to research, development, and the use of specialized materials drive up prices, restricting market access and adoption, particularly in regions with constrained healthcare budgets and emerging economies where affordability is a critical concern.

Market Trends of the Global Occlusion Devices Market

The Global Occlusion Devices market is witnessing a significant shift towards bioresorbable occlusion devices, driven by their ability to dissolve and be absorbed by the body, thereby eliminating the need for device removal procedures. This burgeoning demand is largely fueled by the advantages these devices offer, including minimized long-term complications and enhanced patient comfort. Manufacturers are increasingly channeling investments into research and development to refine bioresorbable materials, focusing on boosting safety and efficacy. This trend reflects a broader movement toward patient-centric healthcare solutions, highlighting a growing preference for personalized treatment options within the realm of occlusion device interventions.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Landscape
  • Case Studies
  • Technological Advancement

Global Occlusion Devices Market Size by Product & CAGR (2025-2032)

  • Market Overview
  • Occlusion Removal Devices
    • Balloon Occlusion Devices
    • Stent Retrievers
    • Coil Retrievers
    • Suction & Aspiration Devices
  • Embolization Devices
    • Embolic Coils
    • Liquid Embolic Agents
    • Tubal Occlusion Devices
  • Support Devices
    • Microcatheters
    • Guidewires

Global Occlusion Devices Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Neurology
  • Cardiology
  • Peripheral Vascular Diseases
  • Urology
  • Oncology
  • Gynecology

Global Occlusion Devices Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Diagnostic Centers,
  • Surgical Centers
  • Ambulatory Care Centers
  • Research Laboratories & Academic Institutes

Global Occlusion Devices Market Size & CAGR (2025-2032)

  • North America (Product, Application, End User)
    • US
    • Canada
  • Europe (Product, Application, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Boston Scientific Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic PLC (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Penumbra, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Edwards Lifesciences Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merit Medical Systems, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lepu Medical Technology Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Asahi Intecc Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AngioDynamics, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardinal Health, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Avinger, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • C.R. Bard, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical Incorporated (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Acrostak International Distribution Sarl (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제